DAWN DEAN: Open Payments
NPI 1720386659 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 42 payments from 9 companies in 2025. Trend: 2023 $324 · 2024 $383 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $398 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $221 |
| Otsuka America Pharmaceutical, Inc. | 5 | $156 |
| Insulet Corporation | 2 | $35 |
| Dexcom, Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $23 |
| Braeburn Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CAPLYTA, REXULTI, QULIPTA, MAVYRET, VRAYLAR, Omnipod, Dexcom G6 Transmitter, VIVITROL.
Industry payments across MO — which companies pay providers there.
